Across TCGA pan-cancer cohorts, CDIPTOSP RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated CDIPTOSP data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CDIPTOSP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDIPTOSP expression acts as an unfavorable survival marker, although some lineages such as LUAD and UVM show a favorable association.

LIHC, LUAD, and UVM are the cancer types where CDIPTOSP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.687	0.880	.001	80	view →
LUAD	DFS	Tertile	All	0.511	0.217	<.001	79	view →
UVM	OS	Median	All	0.735	0.453	.002	62	view →
ACC	DFS	Median	All	0.422	0.804	<.001	54	view →
MESO	OS	Quartile	III,IV	0.103	0.769	.010	42	view →
HNSC	OS	Tertile	IV	0.804	0.636	.002	42	view →
KIRC	OS	Quartile	II,III,IV	0.432	0.695	.011	40	view →
COAD	DFS	Median	IV	0.595	0.352	<.001	36	view →
LUSC	DFS	Quartile	II,III,IV	0.934	0.308	<.001	32	view →
THCA	DFS	Median	II,III,IV	0.770	0.903	.003	26	view →
LGG	DFS	Tertile	All	0.576	0.363	<.001	21	view →
TGCT	DFS	Tertile	All	0.873	0.663	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

Exploration

Same gene, other analysis: CDIPTOSP tumor-vs-normal RNA expression · all CDIPTOSP data types